Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Influenza vaccination in hematopoietic SCT recipients

Bone Marrow Transplantation volume 42, pages 637–641 (2008)Cite this article

Abstract

Influenza is a potentially serious infection after hematopoietic SCT (HSCT). Vaccination is the main prophylactic approach in individuals at an increased risk for severe influenza disease or post-influenza complications. No controlled study on the efficacy of influenza vaccination has been performed in HSCT recipients and also studies evaluating the antibody response are limited by their small sizes and by that vaccinations have been performed at varying times after HSCT. The reports show that serological response rates are lower in HSCT patients than in healthy individuals. However, patients receiving influenza vaccine at 6 months or later after HSCT have a lower risk for virological confirmed influenza. The documentation for efficacy if patients are vaccinated earlier than 6 months after HSCT is mostly lacking but it has been shown that T-cell responses can be elicited after vaccination. Therefore, currently available recommendations suggest starting earlier when the risk for influenza is high, especially during ongoing community outbreaks. Two vaccine doses are recommended in children below the age of 9 years, who have not been previously vaccinated against influenza. Vaccination of family members, close contacts and health-care workers is recommended.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ljungman P, Andersson J, Aschan J, Barkholt L, Ehrnst A, Johansson M et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244–247.

    Article  CAS  Google Scholar 

  2. Aschan J, Ringdén O, Ljungman P, Andersson J, Lewensohn FI, Forsgren M . Influenza B in transplant patients. Scand J Infect Dis 1989; 21: 349–350.

    Article  CAS  Google Scholar 

  3. Whimbey E, Elting LS, Couch RB, Lo W, Williams L, Champlin RE et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437–440.

    CAS  PubMed  Google Scholar 

  4. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.

    Article  CAS  Google Scholar 

  5. Nichols WG, Guthrie KA, Corey L, Boeckh M . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300–1306.

    Article  Google Scholar 

  6. Machado CM, Boas LS, Mendes AV, da Rocha IF, Sturaro D, Dulley FL et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 111–114.

    Article  CAS  Google Scholar 

  7. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409: 1055–1060.

    Article  CAS  Google Scholar 

  8. Treanor J . Influenza virus. In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6th edn. 2005.

  9. Woodland DL, Scott I . T cell memory in the lung airways. Proc Am Thorac Soc 2005; 2: 126–131.

    Article  CAS  Google Scholar 

  10. Ring A, Marx G, Steer C, Harper P . Influenza vaccination and chemotherapy: a shot in the dark? Support Care Cancer 2002; 10: 462–465.

    Article  Google Scholar 

  11. King JJ, Treanor J, Fast P, Wolff M, Yan L, Iacuzio D et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000; 181: 725–728.

    Article  Google Scholar 

  12. King JJ, Fast P, Zangwill K, Weinberg G, Wolff M, Yan L et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr Infect Dis J 2001; 20: 1124–1131.

    Article  Google Scholar 

  13. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82: 1261–1265.

    Article  CAS  Google Scholar 

  14. Mazza J, Yale S, Arrowood J, Reynolds C, Glunich I, Chyou P et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005; 3: 214–220.

    Article  Google Scholar 

  15. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G . Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 1993; 12: 778–782.

    Article  CAS  Google Scholar 

  16. Ljungman P, Nahi H, Linde A . Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Brit J Haematol 2005; 130: 96–98.

    Article  Google Scholar 

  17. van der Velden A, Mulder A, Hartkamp A, Deipersloot R, van Velzen-Blad H, Biesma D . Influenza vaccination and booster in B-cell chronic lymphocytic leukaemia patients. Eur J Intern Med 2001; 12: 420–424.

    Article  Google Scholar 

  18. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1–5.

    CAS  PubMed  Google Scholar 

  19. Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30: 342–348.

    Article  CAS  Google Scholar 

  20. Machado CM, Cardoso MR, da Rocha IF, Boas LS, Dulley FL, Pannuti CS . The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 2005; 36: 897–900.

    Article  CAS  Google Scholar 

  21. Avetisyan G, Aschan J, Hassan M, Ljungman P . Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation 2008; in: press.

    Google Scholar 

  22. Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 2001; 28: 775–781.

    Article  CAS  Google Scholar 

  23. Haining W, Evans J, Seth N, Callaway G, Wucherpfennig K, Nadler L et al. Measuring T cell immunity to influenza vaccination in children after haematopoietic stem cell transplantation. Br J Haematol 2004; 127: 322–325.

    Article  Google Scholar 

  24. Ikegame K, Kaida K, Fujioka T, Kawakami M, Hasei H, Inoue T et al. Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient. Bone Marrow Transplant 2006; 38: 323–324.

    Article  CAS  Google Scholar 

  25. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49 (RR-10): 1–125.

    Google Scholar 

  26. Ljungman P . Immunization of transplant recipients. Bone Marrow Transplant 1999; 23: 635–636.

    Article  CAS  Google Scholar 

  27. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737–746.

    Article  CAS  Google Scholar 

  28. Treanor J, Wright P . Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) 2003; 115: 97–104.

    CAS  Google Scholar 

  29. Murasko D, Bernstein E, Gardner E, Gross P, Munk G, Dran S et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002; 37: 427–439.

    Article  CAS  Google Scholar 

  30. Fiore A, Shay D, Haber P, Iskander J, Uyeki T, Mootrey G et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 13: 1–54.

    Google Scholar 

Download references

Acknowledgements

This study was supported by the Stockholm Cancer Society and the European Leukemia Net.

Author information

Authors and Affiliations

  1. Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

    P Ljungman

  2. Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

    P Ljungman & G Avetisyan

Authors
  1. P Ljungman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Avetisyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P., Avetisyan, G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 42, 637–641 (2008). https://doi.org/10.1038/bmt.2008.264

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.264

Keywords

This article is cited by

Search

Advanced search

Quick links